Acknowledgement
This research was supported by Kyungpook National University Research Fund, 2021.
References
- Pihlstrom BL, Michalowicz BS, Johnson NW: Periodontal diseases. Lancet 366: 1809-1820, 2005. https://doi.org/10.1016/S0140-6736(05)67728-8
- Kinane DF, Stathopoulou PG, Papapanou PN: Periodontal diseases. Nat Rev Dis Primers 3: 17038, 2017. https://doi.org/10.1038/nrdp.2017.38
- Lovegrove JM: Dental plaque revisited: bacteria associated with periodontal disease. J N Z Soc Periodontol (87): 7-21, 2004.
- Genco RJ, Borgnakke WS: Risk factors for periodontal disease. Periodontol 2000 62: 59-94, 2013. https://doi.org/10.1111/j.1600-0757.2012.00457.x
- How KY, Song KP, Chan KG: Porphyromonas gingivalis: an overview of periodontopathic pathogen below the gum line. Front Microbiol 7: 53, 2016. https://doi.org/10.3389/fmicb.2016.00053
- Xu W, Zhou W, Wang H, Liang S: Roles of Porphyromonas gingivalis and its virulence factors in periodontitis. Adv Protein Chem Struct Biol 120: 45-84, 2020. https://doi.org/10.1016/bs.apcsb.2019.12.001
- Bozkurt SB, Hakki SS, Hakki EE, Durak Y, Kantarci A: Porphyromonas gingivalis lipopolysaccharide induces a proinflammatory human gingival fibroblast phenotype. Inflammation 40: 144-153, 2017. https://doi.org/10.1007/s10753-016-0463-7
- Andrukhov O, Ertlschweiger S, Moritz A, Bantleon HP, Rausch-Fan X: Different effects of P. gingivalis LPS and E. coli LPS on the expression of interleukin-6 in human gingival fibroblasts. Acta Odontol Scand 72: 337-345, 2014. https://doi.org/10.3109/00016357.2013.834535
- Liu J, Wang Y, Ouyang X: Beyond toll-like receptors: Porphyromonas gingivalis induces IL-6, IL-8, and VCAM-1 expression through NOD-mediated NF-κB and ERK signaling pathways in periodontal fibroblasts. Inflammation 37: 522-533, 2014. https://doi.org/10.1007/s10753-013-9766-0
- Naruishi K, Nagata T: Biological effects of interleukin-6 on Gingival Fibroblasts: cytokine regulation in periodontitis. J Cell Physiol 233: 6393-6400, 2018. https://doi.org/10.1002/jcp.26521
- Xie X, Liu K, Liu F, et al.: Gossypetin is a novel MKK3 and MKK6 inhibitor that suppresses esophageal cancer growth in vitro and in vivo. Cancer Lett 442: 126-136, 2019. https://doi.org/10.1016/j.canlet.2018.10.016
- Huang K, Liu Z, Kim MO, Kim KR: Anticancer effects of gossypetin from Hibiscus sabdariffa in oral squamous cell carcinoma. J Appl Oral Sci 31: e20230243, 2023. https://doi.org/10.1590/1678-7757-2023-0243
- Diyah NW, Isnaeni, Hidayati SW, Purwanto BT, Siswandono: Design of gossypetin derivatives based on naturally occurring flavonoid in Hibiscus sabdariffa and the molecular docking as antibacterial agents. J Basic Clin Physiol Pharmacol 32: 707-714, 2021. https://doi.org/10.1515/jbcpp-2020-0455
- Proenca C, Rufino AT, Santos I, et al.: Gossypetin is a novel modulator of inflammatory cytokine production and a suppressor of osteosarcoma cell growth. Antioxidants (Basel) 12: 1744, 2023. https://doi.org/10.3390/antiox12091744
- Hoare A, Soto C, Rojas-Celis V, Bravo D: Chronic inflammation as a link between periodontitis and carcinogenesis. Mediators Inflamm 2019: 1029857, 2019. https://doi.org/10.1155/2019/1029857
- Kim AR, Jeong MJ, Ahn YS, Kim MN, Kim SI, Lim DS: The interactive effect of these bacterial substrates on the growth of Streptococcus gordonii, Fusobacterium nucleatum and Porphyromonas gingivalis. J Dent Hyg Sci 15: 209-219, 2015. https://doi.org/10.17135/jdhs.2015.15.2.209
- Beutler B: Endotoxin, toll-like receptor 4, and the afferent limb of innate immunity. Curr Opin Microbiol 3: 23-28, 2000. https://doi.org/10.1016/s1369-5274(99)00046-6
- Herath TD, Darveau RP, Seneviratne CJ, Wang CY, Wang Y, Jin L: Tetra- and penta-acylated lipid A structures of Porphyromonas gingivalis LPS differentially activate TLR4- mediated NF-κB signal transduction cascade and immunoinflammatory response in human gingival fibroblasts. PLoS One 8: e58496, 2013. https://doi.org/10.1371/journal.pone.0058496
- Qiu C, Yuan Z, He Z, et al.: Lipopolysaccharide preparation derived from Porphyromonas gingivalis induces a weaker immuno-inflammatory response in BV-2 microglial cells than Escherichia coli by differentially activating TLR2/4- mediated NF-B/STAT3 signaling pathways. Front Cell Infect Microbiol 11: 606986, 2021. https://doi.org/10.3389/fcimb.2021.606986
- Winning L, Linden G: Periodontitis and systemic disease. BDJ Team 2: 15163, 2015. https://doi.org/10.1038/bdjteam.2015.163
- Sawada S, Chosa N, Ishisaki A, Naruishi K: Enhancement of gingival inflammation induced by synergism of IL-1β and IL-6. Biomed Res 34: 31-40, 2013. https://doi.org/10.2220/biomedres.34.31
- Nakamura A, Uratsuji H, Yamada Y, Hashimoto K, Nozawa N, Matsumoto T: Anti-inflammatory effect of lanoconazole on 12-O-tetradecanoylphorbol-13-acetate- and 2,4,6-trinitrophenyl chloride-induced skin inflammation in mice. Mycoses 63: 189-196, 2020. https://doi.org/10.1111/myc.13034